Monday, October 12, 2026
Adnoc Logistics might acquire stake in HEA
Abu Dhabi National Oil Company's (ADNOC) Logistics and Services unit is currently holding discussions to potentially purchase a stake in UAE-based HEA Energy, which would value the latter at up to $3 billion, the Wall Street Journal reported on Monday.
Sources told the media outlet that Adnoc's unit is considering either acquiring a large minority or a controlling stake in HEA, with the negotiations advancing. Nonetheless, the sources added that nothing has been decided yet and that there is still a possibility that a potential agreement could fall through.
In the second quarter, Adnoc's logistics arm posted a net profit of $951 million, fourfold higher than in the same period a year ago.
https://breakingthenews.net/Article/Adnoc-Logistics-might-acquire-stake-in-HEA/67279623
'Houthis warn of 'swift response' if US joins Yemen war'
Houthi political bureau member Mohammed al-Bukhaiti warned on Monday that the United States will receive a crushing response if it decides to join the Saudi-led coalition's attacks on Yemen's rebel group after reports emerged claiming that Saudi Arabia requested US help in fighting Houthis.
"If the US becomes involved in the aggression against Yemen, we will not deliberate over the decision to respond, rather, there will be a swift and painful response targeting the US and all its interests in the region," he said in an interview with AFP.
The official also called on all employees "at Saudi oil facilities and airports to stay away from these sites, as they have become legitimate targets."
https://breakingthenews.net/Article/Houthis-warn-of-'swift-response'-if-US-joins-Yemen-war/67279889
Mirum Phase III data: Livmarli significantly reduces itch, bile acids in ultra-rare cholestatic liver diseases
- Phase 3 EXPAND study of LIVMARLI (maralixibat) in ultra-rare cholestatic liver diseases met its primary endpoint.
- Detailed results included patients with biliary atresia, expanding evidence for Livmarli in additional ultra-rare cholestatic liver diseases.
- Mirum plans a U.S. sNDA for Livmarli label expansion in the first half of 2027.
JPMorgan upgrades Biogen to Overweight, raises price target to $300
on stronger pipeline catalyst and growth outlook
- Upgrade from Neutral reflects an increasingly compelling pipeline catalyst outlook, according to JPMorgan
- JPMorgan cites improved long-term growth prospects as key support for its new $300 price target
Stryker forms strategic alliance with CMR Surgical, makes $400M preferred equity investment, gains U.S. rights
, future acquisition option
- Alliance includes exclusive U.S. sales rights for CMR Surgical's Versius surgical robotics portfolio in the United States.
- Stryker receives an option to acquire 100% of CMR Surgical at a future date.
STERIS announces $2.1 billion acquisition of Xodus Medical
expected to be accretive to revenue growth, margins and adjusted earnings
- Acquisition of Xodus Medical expands STERIS's surgical consumables portfolio in a $2.1 billion transaction.